Estimation of plasma apolipoprotein B concentration using routinely measured lipid biochemical tests in apparently healthy Asian adults

@article{Cho2012EstimationOP,
  title={Estimation of plasma apolipoprotein B concentration using routinely measured lipid biochemical tests in apparently healthy Asian adults},
  author={Dong-sik Cho and S. Woo and S. Kim and C. Byrne and J. Kong and K. Sung},
  journal={Cardiovascular Diabetology},
  year={2012},
  volume={11},
  pages={55 - 55}
}
BackgroundIncreased low-density lipoprotein cholesterol (LDL) concentration is associated with increased risk of coronary heart disease (CHD) but a substantial risk of cardiovascular disease often remains after LDL concentrations have been treated to target. Apolipoprotein B (apo B) is the major apolipoprotein contained within atherogenic lipoproteins such as LDL, and apo B is a more reliable indicator of cardiovascular risk than LDL concentration.Aim and methodsOur aim was to develop a formula… Expand
View on Springer
cardiab.biomedcentral.com
13 Citations
Highly Influential Citations
3
Background Citations
6
Methods Citations
4

13 Citations

Citation Type

Citation Type

Validation of a Newly Developed Equation for Estimating Serum Apolipoprotein B: Associations with Cardiovascular Disease Surrogate Markers in Koreans
  • Highly Influenced
  • PDF
AGREEMENT BETWEEN ESTIMATED APOLIPOPROTEIN B -100 CONCENTRATION AND APOLIPOPROTEIN B-100 CONCENTRATION MEASURED BY IMMUNOTURBIDIMETRIC METHOD
  • Highly Influenced
Apolipoprotein E gene polymorphism and renal function are associated with apolipoprotein E concentration in patients with chronic kidney disease
  • 2
Discriminant ratio and biometrical equivalence of measured vs. calculated apolipoprotein B100 in patients with T2DM
  • 8
  • Highly Influenced
Association of lowering apolipoprotein B with cardiovascular outcomes across various lipid-lowering therapies: Systematic review and meta-analysis of trials
  • 7
Temporal changes in concentrations of lipids and apolipoprotein B among adults with diagnosed and undiagnosed diabetes, prediabetes, and normoglycemia: findings from the National Health and Nutrition Examination Survey 1988–1991 to 2005–2008
  • 15
Sagittal abdominal diameter is a more independent measure compared with waist circumference to predict arterial stiffness in subjects with type 2 diabetes - a prospective observational cohort study
  • 41
  • PDF
Recent clinical trials evaluating benefit of drug therapy for modification of HDL cholesterol
  • R. Wright
  • Medicine
  • Current opinion in cardiology
  • 2013
  • 39
Protective and therapeutic effects of Trianthema portulacastrum against atherosclerosis in male albino rats via G-protein-coupled receptor 124
Guggulsterone, a farnesoid X receptor antagonist lowers plasma trimethylamine-N-oxide levels: An evidence from in vitro and in vivo studies
  • 5
...
1
2
...

References

SHOWING 1-10 OF 45 REFERENCES
Apolipoprotein B and cardiovascular disease risk: position statement from the AACC Lipoproteins and Vascular Diseases Division Working Group on Best Practices.
  • 268
  • PDF
Apolipoprotein Measurements: Is More Widespread Use Clinically Indicated?
  • 78
Comparison of the relationships between serum apolipoprotein B and serum lipid distributions.
  • 21
  • PDF
Estimation of LDL cholesterol based on the Friedewald formula and on apo B levels.
  • 74
Non-HDL cholesterol and apolipoprotein B predict cardiovascular disease events among men with type 2 diabetes.
  • 243
  • PDF
Association between plasma lipids, and apolipoproteins and coronary artery disease: a cross-sectional study in a low-risk Korean population.
  • 43
Apo B versus cholesterol in estimating cardiovascular risk and in guiding therapy: report of the thirty‐person/ten‐country panel
  • 441
Serum Non-high-density lipoprotein cholesterol concentration and risk of death from cardiovascular diseases among U.S. adults with diagnosed diabetes: the Third National Health and Nutrition Examination Survey linked mortality study
  • 28
  • PDF
Comparison of the Associations of Apolipoprotein B and Low-Density Lipoprotein Cholesterol With Other Cardiovascular Risk Factors in the Insulin Resistance Atherosclerosis Study (IRAS)
  • 133
  • PDF
Non-HDL-cholesterol as valid surrogate to apolipoprotein B100 measurement in diabetes: Discriminant Ratio and unbiased equivalence
  • 57
  • Highly Influential
...
1
2
3
4
5
...